Purchases and Sales Made in Q2 2024 in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI) during Q2 2024. The information is specifically focused on institutions that hold shares of BioXcel Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-8.19K- 91.62% |
$9.33K - $24.3K
|
749
$1.59K
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-10.8K- 25.65% |
$12.3K - $32.1K
|
31.3K
$66.4K
|
|
|
Aug 06, 2024
Q2 2024
|
Davenport & CO LLC
|
SELL
|
- |
-13.2K- 38.33% |
$15K - $39.1K
|
21.2K
$45K
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-14.6K- 99.07% |
$16.7K - $43.5K
|
137
$290
|
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-16.6K- 7.87% |
$19K - $49.4K
|
195K
$413K
|
|
|
Aug 01, 2024
Q2 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-18.2K- 61.25% |
$20.7K - $54K
|
11.5K
$24.4K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-94.7K- 64.34% |
$108K - $281K
|
52.5K
$111K
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-106K- 47.56% |
$121K - $314K
|
117K
$247K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-106K- 47.56% |
$121K - $314K
|
117K
$247K
|
|
|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-129K- 11.73% |
$147K - $383K
|
970K
$2.06M
|
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-191K- 41.75% |
$218K - $568K
|
267K
$565K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-340K- 73.17% |
$388K - $1.01M
|
125K
$264K
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-887K- 66.82% |
$1.01M - $2.64M
|
441K
$934K
|